D
Teva Pharmaceutical Industries Limited TEVA
$14.81 $0.0850.58% NYSE
Recommendation
Prev Close
$14.72
Volume
3,771,592
Avg Vol (90D)
12,620,215
Market Cap
$16.88B
Dividend & Yield
--
52-Week Range
$12.47 - $22.80
P/E (TTM)
--
EPS (TTM)
-$1.46
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
MarketBeat Week in Review – 02/03 - 02/07
2/8/2025 - MarketBeat
Eversept Partners LP Sells 992,513 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/24/2025 - MarketBeat
Teva Pharmaceutical Industries (TEVA, $14) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 22, 2025
4/23/2025 - Tickeron - Technical Analysis
CANADA LIFE ASSURANCE Co Raises Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/23/2025 - MarketBeat
Teva Pharmaceutical Industries Ltd (TEVA) Shares Up 5.15% on Apr 22
4/22/2025 - GuruFocus
Teachers Retirement System of The State of Kentucky Invests $37.69 Million in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/22/2025 - MarketBeat
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?
4/21/2025 - Zacks Investment Research
Forum Financial Management LP Acquires 7,748 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/21/2025 - Ticker Report
Gamco Investors INC. ET AL Reduces Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/20/2025 - MarketBeat
39,413 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Bought by CreativeOne Wealth LLC
4/20/2025 - MarketBeat
Marshall Wace LLP Purchases 2,410,420 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/19/2025 - MarketBeat
Gabelli Funds LLC Acquires 183,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/19/2025 - MarketBeat
Townsquare Capital LLC Acquires 812 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/19/2025 - Ticker Report
Russell Investments Group Ltd. Has $4.51 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/18/2025 - MarketBeat
Video: Thursday's ETF with Unusual Volume: PABD
4/17/2025 - Market News Video
Here's How You Should Play JNJ Stock After Q1 Earnings Beat
4/17/2025 - Zacks Investment Research
Affinity Asset Advisors LLC Sells 1,000,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/17/2025 - MarketBeat
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Holdings Increased by Jump Financial LLC
4/17/2025 - MarketBeat
Marshall Wace LLP Has $113.63 Million Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/17/2025 - Ticker Report
Franklin Resources Inc. Has $1.03 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
4/17/2025 - MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Hold Rating by StockNews.com
4/17/2025 - MarketBeat
Teva Pharmaceutical Industries Target of Unusually High Options Trading (NYSE:TEVA)
4/16/2025 - MarketBeat
Billionaire Sold Broadcom And Bought This Stock That Could Soar 121%
4/16/2025 - 24/7 Wall St.
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals
4/16/2025 - Zacks Investment Research
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
2/3/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$16.54B
EBITDA (TTM)
$4.43B
EBIT (TTM)
$3.37B
Net Income (TTM)
-$1.64B
Balance Sheet
Total Assets (Q)
$39.33B
Total Debt (Q)
$18.18B
Total Liabilities (Q)
$33.61B
Book Value Per Share (Q)
$4.74
Cash Flow
Cash from Operations (TTM)
$1.25B
Cash from Investing (TTM)
$792.00M
Cash from Financing (TTM)
-$1.79B
Net Change in Cash (TTM)
$73.00M
Filings
Filing Date
Wednesday, February 5, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.76
7-Day Total Return
8.86%
30-Day Total Return
-10.05%
60-Day Total Return
-20.15%
90-Day Total Return
-11.93%
Year to Date Total Return
-30.49%
1-Year Total Return
11.74%
2-Year Total Return
79.89%
3-Year Total Return
62.16%
5-Year Total Return
38.11%
52-week Low
Apr 10, 2025 - $12.47
52-week High
Dec 26, 2024 - $22.80
Valuation
Market Cap
$16.88B - Large Cap
Enterprise Value
$32.11B
Price/Sales (TTM)
1.01
Price/Book (Q)
3.11
Dividends and Shares
Shares Outstanding
1.13B
Dividend Per Share (Most Recent)
$0.0723
Dividend Per Share (TTM)
--
Corporate Info
Website
www.tevapharm.com
Phone Number
972 3 914 8213
Address
124 Dvora HaNevi’a St.
Tel Aviv, 6944020
Country
Israel
Year Founded
1901
Business Description
Sector
--
Industry
--
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and... more
NYSE 04/25/2025 2:44PM Eastern Quotes delayed